Prestige Consumer Healthcare Inc. (PBH)
NYSE: PBH · Real-Time Price · USD
58.51
-0.71 (-1.20%)
Mar 30, 2026, 4:00 PM EDT - Market closed
PBH Market Cap
PBH has a market cap or net worth of $2.77 billion as of March 31, 2026. Its market cap has decreased by -33.22% in one year.
Market Cap
2.77B
Enterprise Value
3.79B
1-Year Change
-33.22%
Ranking
Category
Stock Price
$58.51
Market Cap Chart
Since February 10, 2005, PBH's market cap has increased from $887.50M to $2.77B, an increase of 211.96%. That is a compound annual growth rate of 5.53%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 30, 2026 | 2.77B | -6.66% |
| Dec 31, 2025 | 2.97B | -23.12% |
| Dec 31, 2024 | 3.86B | 27.01% |
| Dec 29, 2023 | 3.04B | -2.02% |
| Dec 30, 2022 | 3.10B | 2.02% |
| Dec 31, 2021 | 3.04B | 73.93% |
| Dec 31, 2020 | 1.75B | -14.12% |
| Dec 31, 2019 | 2.03B | 27.33% |
| Dec 31, 2018 | 1.60B | -32.17% |
| Dec 29, 2017 | 2.36B | -14.59% |
| Dec 30, 2016 | 2.76B | 1.57% |
| Dec 31, 2015 | 2.72B | 49.91% |
| Dec 31, 2014 | 1.81B | -2.16% |
| Dec 31, 2013 | 1.85B | 83.02% |
| Dec 31, 2012 | 1.01B | 77.97% |
| Dec 30, 2011 | 568.40M | -4.95% |
| Dec 31, 2010 | 598.00M | 52.09% |
| Dec 31, 2009 | 393.20M | -25.36% |
| Dec 31, 2008 | 526.80M | 40.86% |
| Dec 31, 2007 | 374.00M | -42.56% |
| Dec 29, 2006 | 651.10M | 4.09% |
| Dec 30, 2005 | 625.50M | -29.52% |
| Feb 10, 2005 | 887.50M | - |
View and export this data all the way back to 2005. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkermes | 4.90B |
| Lantheus Holdings | 4.84B |
| Hims & Hers Health | 4.42B |
| Amneal Pharmaceuticals | 3.78B |
| Kiniksa Pharmaceuticals International, | 3.50B |
| Liquidia | 3.09B |
| Supernus Pharmaceuticals | 2.85B |
| BioCryst Pharmaceuticals | 2.34B |